Detalles de la búsqueda
1.
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Antimicrob Agents Chemother
; 65(8): e0004521, 2021 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33972253
2.
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015035
3.
Prolonged vs short-term infusion of ß-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis.
J Infect
; 87(3): 190-198, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423503
4.
Recommendations on the use of azole antifungals in hematology-oncology patients.
Rev Esp Quimioter
; 36(3): 236-258, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017117
5.
Decreased mortality among patients with catheter-related bloodstream infections at Catalan hospitals (2010-2019).
J Hosp Infect
; 126: 70-77, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35594988
6.
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
J Antimicrob Chemother
; 66(3): 657-63, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21193475
7.
Effect of statins on outcomes in immunosuppressed patients with bloodstream infection.
Eur J Clin Microbiol Infect Dis
; 30(1): 77-82, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20835878
8.
Risk factors for, and clinical relevance of, faecal extended-spectrum ß-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
Eur J Clin Microbiol Infect Dis
; 30(3): 355-60, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21052757
9.
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Trials
; 22(1): 116, 2021 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33546739
10.
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study.
J Infect
; 83(3): 306-313, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302864
11.
Efficacy of extended infusion of ß-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Trials
; 21(1): 412, 2020 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423462
12.
Clinical features and outcomes of Legionnaires' disease in solid organ transplant recipients.
Transpl Infect Dis
; 11(1): 78-82, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18713136
13.
Is hospital-acquired pneumonia different in transplant recipients?
Clin Microbiol Infect
; 25(10): 1186-1194, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30986554
14.
Update on the management of febrile neutropenia in hematologic patients.
Rev Esp Quimioter
; 32 Suppl 2: 55-58, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475812
15.
Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era.
Clin Transl Oncol
; 21(2): 187-196, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948973
16.
Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer.
Antimicrob Agents Chemother
; 52(11): 4187-90, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18809942
17.
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
J Hosp Infect
; 68(2): 116-22, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18226420
18.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).
Clin Microbiol Infect
; 24 Suppl 2: S83-S94, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572070
19.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52).
Clin Microbiol Infect
; 24 Suppl 2: S71-S82, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447988
20.
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Trials
; 19(1): 264, 2018 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720244